This week's View delves into how evidence-based treatments of non-ST-segment elevation (NSTE) myocardial infarction affect short- and long-term outcomes, the modes of death following NSTE acute coronary syndromes in clinical trial populations, and key points from the 2018 ESC Guidelines for the Management of Cardiovascular Diseases During Pregnancy.

Subscribe on iTunes | Subscribe on Google Play

Keywords: EaglesEyeView, Acute Coronary Syndrome, Aneurysm, Dissecting, Anticoagulants, Aortic Coarctation, Aortic Valve Stenosis, Arrhythmias, Cardiac, Blood Pressure, Body Surface Area, Bromocriptine, Cardiomyopathy, Dilated, Cardiology Interventions, Coronary Artery Bypass, Coronary Angiography, Creatine Kinase, MB Form, Death, Sudden, Diabetes Mellitus, Dilatation, Electrocardiography, Geriatrics, Guideline Adherence, Heart Defects, Congenital, Heart Failure, Labetalol, Heart Valve Diseases, Heart Valve Prosthesis, Hemorrhage, Heparin, Heparin, Low-Molecular-Weight, Hypertension, Hypertension, Pregnancy-Induced, Hypertension, Pulmonary, Intracranial Hemorrhages, Lactation, Marfan Syndrome, Methyldopa, Mitral Valve Stenosis, Myocardial Infarction, Myocardial Revascularization, Outcome Assessment, Health Care, Percutaneous Coronary Intervention, Peripartum Period, Pregnancy, Primary Prevention, Risk Assessment, Secondary Prevention, Smoking, Treatment Outcome, Troponin, Turner Syndrome, Ventricular Dysfunction, Ventricular Function, Warfarin, Women, Thoracic Surgery, Diagnostic Imaging

< Back to Listings